Arcturus Therapeutics Holdings Inc (ARCT)
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
Neurocrine Biosciences Inc (NBIX)
Neurocrine Biosciences Reports Third Quarter 2025 Financial Results
Alpha Teknova Inc (TKNO)
Teknova to Report Third Quarter 2025 Financial Results on November 6, 2025
BridgeBio Pharma (BBIO)
BridgeBio to Report Phase 3 Results for Encaleret in ADH1 CALIBRATE Study on Wednesday, October 29th
Spectral AI (MDAIW)
Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call
Spectral AI (MDAI)
Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call
DexCom Inc (DXCM)
Rosen Law Firm Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Eli Lilly and Company (LLY)
Lilly partners with NVIDIA to build the industrys most powerful AI supercomputer, supercharging medicine discovery and delivery for patients
Prenetics Global Ltd (PRE)
Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy
Capricor Therapeutics Inc. (CAPR)
Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm